Using murine model, human liver cancer cells, gene expression profiling and computer-assisted modeling analyses, Amin's study identified "NF-kB" as a regulatory hub and a candidate therapeutic drug target for liver cancer.
Using murine model, human liver cancer cells, gene expression profiling and computer-assisted modeling analyses, Amin's study identified "NF-kB" as a regulatory hub and a candidate therapeutic drug target for liver cancer.